Showing results (41-50 of 376) with videos related to
Sort By:
Pageof 38
Expert Opinion on Pharmacotherapy|March 21, 2013
Stavudine extended release (once-daily, Bristol-Myers Squibb) for the treatment of HIV/AIDSMa Gracia Mateo, Ma del Mar Gutierrez, Francesc Vidal, et al.Expert Opinion on Drug Safety|March 7, 2014
Drug safety profile of integrase strand transfer inhibitorsMaria del Mar Gutierrez, Maria Gracia Mateo, Francesc Vidal, et al.AIDS Reviews|December 15, 2004
Could mitochondrial DNA quantitation be a surrogate marker for drug mitochondrial toxicity?Carmen de Mendoza, Matilde Sanchez-Conde, Esteve Ribera, et al.HIV Research & Clinical Practice|February 18, 2020
Long-term efficacy and safety of nevirapine-containing regimens in virologically suppressed patients: a 17-year follow upJuan Tiraboschi, Natalia Lattour, Hernando Knobel, et al.Journal of Clinical Medicine|June 10, 2023
Acute Bacterial Meningitis in Healthy Adult Patients: A Prospective Cohort StudyVirginia Pomar, Natividad Benito, Pol Duch, et al.Ebiomedicine|August 1, 2020
The four horsemen of a viral Apocalypse: The pathogenesis of SARS-CoV-2 infection (COVID-19)Pere Domingo, Isabel Mur, Virginia Pomar, et al.Medicina Clinica|April 6, 2006
[Frequency of thiopurine S-methyltransferase alleles in different ethnic groups living in Spain]Hector Corominas, Montserrat Domènech, Elisabeth del Río, et al.BMC Infectious Diseases|October 2, 2013
Spontaneous gram-negative bacillary meningitis in adult patients: characteristics and outcomeVirginia Pomar, Natividad Benito, Joaquin López-Contreras, et al.Expert Opinion on Drug Metabolism & Toxicology|September 13, 2019
Drug-drug interactions when treating HIV-related metabolic disordersMaria Del Mar Gutierrez, Mª Gracia Mateo, Noemí Corbacho, et al.Expert Opinion on Pharmacotherapy|February 26, 2021
Pharmacological considerations for the treatment of COVID-19 in people living with HIV (PLWH)María Del Mar Gutierrez, Isabel Mur, María Gracia Mateo, et al.Pageof 38